Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration

NCT01922128 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonexudative Age-related Macular Degeneration

Interventions

DRUG: MC-1101, Placebo

Sponsor

MacuCLEAR, Inc.